title: Continuous multi-parameter heart rate variability analysis heralds onset of sepsis in adults.
abstract: BACKGROUND
  Early diagnosis of sepsis enables timely resuscitation and antibiotics and prevents subsequent morbidity and mortality. Clinical approaches relying on point-in-time analysis of vital signs or lab values are often insensitive, non-specific and late diagnostic markers of sepsis. Exploring otherwise hidden information within intervals-in-time, heart rate variability (HRV) has been documented to be both altered in the presence of sepsis, and correlated with its severity. We hypothesized that by continuously tracking individual patient HRV over time in patients as they develop sepsis, we would demonstrate reduced HRV in association with the onset of sepsis.
  
  
  RESULTS
  We monitored heart rate continuously in adult bone marrow transplant (BMT) patients (n = 21) beginning a day before their BMT and continuing until recovery or withdrawal (12+/-4 days). We characterized HRV continuously over time with a panel of time, frequency, complexity, and scale-invariant domain techniques. We defined baseline HRV as mean variability for the first 24 h of monitoring and studied individual and population average percentage change (from baseline) over time in diverse HRV metrics, in comparison with the time of clinical diagnosis and treatment of sepsis (defined as systemic inflammatory response syndrome along with clinically suspected infection requiring treatment). Of the 21 patients enrolled, 4 patients withdrew, leaving 17 patients who completed the study. Fourteen patients developed sepsis requiring antibiotic therapy, whereas 3 did not. On average, for 12 out of 14 infected patients, a significant (25%) reduction prior to the clinical diagnosis and treatment of sepsis was observed in standard deviation, root mean square successive difference, sample and multiscale entropy, fast Fourier transform, detrended fluctuation analysis, and wavelet variability metrics. For infected patients (n = 14), wavelet HRV demonstrated a 25% drop from baseline 35 h prior to sepsis on average. For 3 out of 3 non-infected patients, all measures, except root mean square successive difference and entropy, showed no significant reduction. Significant correlation was present amongst these HRV metrics for the entire population.
  
  
  CONCLUSIONS
  Continuous HRV monitoring is feasible in ambulatory patients, demonstrates significant HRV alteration in individual patients in association with, and prior to clinical diagnosis and treatment of sepsis, and merits further investigation as a means of providing early warning of sepsis.
authors.affiliation: Ottawa Hospital Research Institute, Ottawa, Ontario, Canada.
authors.forename: Saif
authors.initials: S
authors.lastname: Ahmad
authors.forename: Tim
authors.initials: T
authors.lastname: Ramsay
authors.forename: Lothar
authors.initials: L
authors.lastname: Huebsch
authors.forename: Sarah
authors.initials: S
authors.lastname: Flanagan
authors.forename: Sheryl
authors.initials: S
authors.lastname: McDiarmid
authors.forename: Izmail
authors.initials: I
authors.lastname: Batkin
authors.forename: Lauralyn
authors.initials: L
authors.lastname: McIntyre
authors.forename: Sudhir R
authors.initials: SR
authors.lastname: Sundaresan
authors.forename: Donna E
authors.initials: DE
authors.lastname: Maziak
authors.forename: Farid M
authors.initials: FM
authors.lastname: Shamji
authors.forename: Paul
authors.initials: P
authors.lastname: Hebert
authors.forename: Dean
authors.initials: D
authors.lastname: Fergusson
authors.forename: Alan
authors.initials: A
authors.lastname: Tinmouth
authors.forename: Andrew J E
authors.initials: AJ
authors.lastname: Seely
mesh_terms: D000328:Adult; D005240:Feasibility Studies; D005260:Female; D006339:Heart Rate; D006801:Humans; D008297:Male; D008875:Middle Aged; D018805:Sepsis / Q000503:physiopathology*
references.citation: N Engl J Med. 2001 Nov 8;345(19):1368-77
references.pmid: 11794169
references.citation: Acad Emerg Med. 2002 Jul;9(7):661-70
references.pmid: 12093705
references.citation: Shock. 2001 Oct;16(4):274-7
references.pmid: 11580109
references.citation: Pediatrics. 2005 Nov;116(5):1070-4
references.pmid: 16263991
references.citation: Crit Care Med. 1996 Jul;24(7):1107-16
references.pmid: 8674321
references.citation: Circulation. 1997 Aug 19;96(4):1185-91
references.pmid: 9286948
references.citation: Am J Respir Crit Care Med. 1999 Aug;160(2):458-65
references.pmid: 10430714
references.citation: Br J Haematol. 2005 Jun;129(6):713-22
references.pmid: 15952996
references.citation: Intensive Care Med. 2003 Jan;29(1):135-8
references.pmid: 12528035
references.citation: Intensive Care Med. 1995 Feb;21(2):112-9
references.pmid: 7775691
references.citation: Neurobiol Aging. 2002 Jan-Feb;23(1):23-6
references.pmid: 11755014
references.citation: Ann Oncol. 2006 Mar;17(3):507-14
references.pmid: 16322116
references.citation: Clin Auton Res. 1993 Feb;3(1):5-13
references.pmid: 8386574
references.citation: Am J Emerg Med. 2008 May;26(4):395-401
references.pmid: 18410805
references.citation: Crit Care Med. 2001 Jul;29(7):1303-10
references.pmid: 11445675
references.citation: Ann Biomed Eng. 2004 Feb;32(2):233-44
references.pmid: 15008371
references.citation: Dis Mon. 2001 Oct;47(10):465-532
references.pmid: 11641650
references.citation: Bone Marrow Transplant. 2000 Jul;26(2):211-4
references.pmid: 10918433
references.citation: J Crit Care. 2003 Sep;18(3):156-63
references.pmid: 14595568
references.citation: Crit Care Med. 2000 Jul;28(7):2193-200
references.pmid: 10921540
references.citation: Crit Care Med. 2001 Jul;29(7):1380-5
references.pmid: 11445691
references.citation: Crit Care. 2004 Dec;8(6):R367-84
references.pmid: 15566580
references.citation: Crit Care Med. 2006 Jun;34(6):1589-96
references.pmid: 16625125
references.citation: Chest. 2006 Nov;130(5):1579-95
references.pmid: 17099041
references.citation: Diabetes Care. 2004 Dec;27(12):2942-7
references.pmid: 15562211
references.citation: J Crit Care. 2006 Sep;21(3):280-6
references.pmid: 16990099